26.64
price up icon1.29%   0.34
after-market After Hours: 26.62 -0.02 -0.08%
loading

Pfizer Inc Stock (PFE) Forecast

The Pfizer Inc (PFE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $25.98, representing a -2.49% decrease from the current price of $26.64. The highest analyst price target is $28.11, and the lowest is $23.84.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PFE Price Target
Average 22.50 (-15.54% Downside)
loading

Is Pfizer Inc (PFE) A Buy Now?

Oscillators
Name Value Action
RSI(14) 52.78 Neutral
STOCH(9,6) 25.50 Neutral
STOCHRSI(14) 44.65 Neutral
MACD(12,26) 0.0727 Sell
ADX(14) 16.33 Neutral
William %R -57.76 Neutral
CCI(14) -13.90 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
26.65
Sell
26.53
Buy
MA20
26.57
Buy
26.48
Buy
MA50
26.12
Buy
26.63
Buy
MA100
27.55
Sell
27.17
Sell
MA200
27.87
Sell
27.86
Sell
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, PFE could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on PFE, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 52.78 indicates that PFE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 25.5 indicates that PFE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.65 indicates that PFE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 16.33 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.9 indicates that PFE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term PFE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Pfizer Inc financial reports and earnings history, Pfizer Inc (PFE) stock could reach $16.48 by 2030, $12.21 by 2040 and $7.8598 by 2050. See the projected annual prices until 2050 of the Pfizer Inc stock below:

  • Pfizer Inc (PFE) is expected to reach an average price of $11.62 in 2035, with a high prediction of $12.47 and a low estimate of $10.02. This indicates an $-56.38% rise from the last recorded price of $26.64.
  • Pfizer Inc (PFE) stock is projected to chart a bullish course in 2040, with an average price target of $9.0208, representing an $-66.14% surge from its current level. The forecast ranges from a conservative $8.4408 to a sky-high $12.21.
  • Our analysts predict Pfizer Inc (PFE) to jump -98.17% by 2045, soaring from $0.0873 to an average price of $0.4865, potentially reaching $6.334. While $0.0873 is the low estimate, the potential upside is significant.
  • Pfizer Inc (PFE) stock is expected to climb by 2050, reaching an average of $0.2916, a $-98.91% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.8598 and $4.4116, respectively, highlighting the market's uncertainty.

Pfizer Inc Stock (PFE) Year by Year Forecast

Pfizer Inc Stock (PFE) Price Forecast for 2025

Pfizer Inc Stock (PFE) is expected to reach an average price of $21.63 in 2025, with a high prediction of $28.11 and a low estimate of $15.16. This indicates an -18.80% fall from the last recorded price of $26.64.
Month Average Low High Change from today's price
February, 2025 $24.30 $23.84 $28.11 -8.79%
March, 2025 $19.77 $19.74 $25.70 -25.77%
April, 2025 $20.06 $15.16 $23.54 -24.70%
May, 2025 $23.70 $18.84 $24.26 -11.05%
June, 2025 $25.19 $24.00 $26.59 -5.45%
July, 2025 $20.91 $20.21 $25.88 -21.52%
August, 2025 $21.38 $19.11 $22.51 -19.75%
September, 2025 $26.07 $22.08 $27.04 -2.14%
October, 2025 $24.05 $23.56 $26.70 -9.74%
November, 2025 $24.43 $23.11 $25.25 -8.31%
December, 2025 $23.31 $22.42 $26.66 -12.51%

Pfizer Inc Stock (PFE) Price Forecast for 2026

The predicted value for Pfizer Inc (PFE) in 2026 is set at an average of $30.91. Estimates vary from a peak of $40.37 to a trough of $21.46, indicating an +16.04% surge from the present price of $26.64.
Month Average Low High Change from today's price
January, 2026 $25.11 $23.38 $29.84 -5.73%
February, 2026 $25.63 $25.25 $31.01 -3.77%
March, 2026 $24.71 $24.26 $25.84 -7.26%
April, 2026 $22.53 $22.32 $25.64 -15.42%
May, 2026 $23.65 $21.46 $24.11 -11.22%
June, 2026 $24.84 $23.41 $25.01 -6.75%
July, 2026 $28.28 $24.55 $29.35 +6.15%
August, 2026 $28.46 $26.80 $29.06 +6.83%
September, 2026 $28.05 $27.06 $28.52 +5.28%
October, 2026 $33.54 $27.96 $34.34 +25.89%
November, 2026 $34.62 $33.60 $40.37 +29.95%
December, 2026 $31.62 $31.04 $36.07 +18.71%

Pfizer Inc Stock (PFE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Pfizer Inc (PFE) is $40.07, with a high forecast of $50.54 and a low forecast of $29.60. This indicates an +50.41% increase from the last price of $26.64.
Month Average Low High Change from today's price
January, 2027 $31.83 $29.60 $31.99 +19.47%
February, 2027 $39.54 $31.26 $41.57 +48.41%
March, 2027 $48.29 $39.05 $50.24 +81.27%
April, 2027 $43.82 $42.80 $50.54 +64.50%
May, 2027 $41.93 $38.72 $43.75 +57.41%
June, 2027 $37.66 $34.38 $42.53 +41.36%
July, 2027 $40.84 $35.49 $44.35 +53.30%
August, 2027 $37.26 $37.03 $45.44 +39.87%
September, 2027 $43.12 $36.27 $44.13 +61.85%
October, 2027 $35.77 $35.55 $43.81 +34.26%
November, 2027 $42.51 $36.24 $43.25 +59.57%
December, 2027 $39.51 $37.21 $43.08 +48.33%

Pfizer Inc Stock (PFE) Price Forecast for 2028

In 2028, Pfizer Inc (PFE) is projected to reach an average price of $35.30, with a high projection of $44.65 and a low estimate of $25.96. This indicates an +32.53% rise from the last price of $26.64.
Month Average Low High Change from today's price
January, 2028 $35.17 $34.58 $39.60 +32.00%
February, 2028 $33.29 $33.03 $37.85 +24.95%
March, 2028 $36.15 $31.00 $37.11 +35.71%
April, 2028 $38.87 $35.78 $39.47 +45.92%
May, 2028 $41.57 $38.72 $44.65 +56.04%
June, 2028 $34.91 $34.44 $41.68 +31.04%
July, 2028 $33.74 $32.53 $35.14 +26.66%
August, 2028 $29.33 $29.17 $34.08 +10.09%
September, 2028 $31.50 $29.21 $32.22 +18.24%
October, 2028 $28.55 $28.08 $32.00 +7.17%
November, 2028 $28.49 $26.26 $30.24 +6.96%
December, 2028 $26.88 $25.96 $30.53 +0.88%

Pfizer Inc Stock (PFE) Price Forecast for 2029

The 2029 price forecast for Pfizer Inc Stock (PFE) is $20.49 on average, with a high prediction of $28.06 and a low estimate of $12.93. This represents an -23.07% decrease from the previous price of $26.64.
Month Average Low High Change from today's price
January, 2029 $26.33 $25.56 $28.06 -1.16%
February, 2029 $26.71 $24.94 $27.52 +0.27%
March, 2029 $24.46 $23.93 $27.29 -8.17%
April, 2029 $22.56 $22.20 $24.55 -15.30%
May, 2029 $20.01 $19.56 $24.39 -24.89%
June, 2029 $19.50 $18.89 $21.33 -26.80%
July, 2029 $19.44 $16.38 $20.25 -27.02%
August, 2029 $17.81 $17.51 $20.95 -33.15%
September, 2029 $18.55 $17.28 $18.93 -30.37%
October, 2029 $18.22 $16.44 $19.54 -31.59%
November, 2029 $16.93 $16.16 $19.00 -36.46%
December, 2029 $13.69 $12.93 $18.42 -48.59%

Pfizer Inc Stock (PFE) Price Forecast for 2030

Pfizer Inc Stock (PFE) is expected to reach an average price of $10.13 in 2030, with a high forecast of $17.83 and a low forecast of $2.4305. This signifies an -61.97% decrease from the last price of $26.64.
Month Average Low High Change from today's price
January, 2030 $15.96 $12.92 $16.48 -40.08%
February, 2030 $15.69 $15.31 $17.83 -41.11%
March, 2030 $11.57 $11.10 $16.59 -56.55%
April, 2030 $9.0516 $7.4557 $12.00 -66.02%
May, 2030 $9.6787 $9.087 $11.37 -63.67%
June, 2030 $10.66 $8.3291 $10.70 -59.98%
July, 2030 $12.28 $10.24 $12.82 -53.91%
August, 2030 $13.50 $11.82 $13.63 -49.33%
September, 2030 $13.60 $12.87 $13.84 -48.96%
October, 2030 $10.91 $10.79 $15.25 -59.05%
November, 2030 $6.3096 $4.5746 $11.44 -76.32%
December, 2030 $8.0313 $2.4305 $8.5013 -69.85%
$274.81
price up icon 0.99%
drug_manufacturers_general SNY
$51.69
price up icon 1.87%
$92.96
price up icon 1.22%
drug_manufacturers_general NVS
$99.73
price up icon 2.26%
drug_manufacturers_general MRK
$96.24
price down icon 1.72%
Cap:     |  Volume (24h):